A study out of Israel suggests the Pfizer vaccine is resulting in a dramatic reduction in the number of COVID cases in a key demographic. The over 60s are the most vulnerable to COVID and Israeli doctors report a 60% drop in that age group.
Further, they were not expecting to see any results from the vaccination rollout until at least mid-February.
The Daily Mail explains:
An Israeli healthcare group on Friday said coronavirus infections had plunged among people aged over 60 who had been vaccinated with the Pfizer Biontech vaccine.
Israel is currently leading the global vaccination drive, with around 30 per cent of its citizens having had at least a single dose of a jab so far.
But concern had risen globally over infection, death and hospitalisation rates in the country, which remained stubbornly high.
Out of 82,930 active cases on Thursday, 1,918 were hospitalized. Last week, the hospitalisation figure was just over 1,000.
Pfizer also requires two doses and after the second dose, Israeli doctors also reported such a surge in antibodies that they believe people who are vaccinated will not spread the virus to other people. READ: Pfizer’s Covid vaccine COULD stop people spreading the virus as well as preventing serious illness, Israeli doctor claims after finding antibody levels surged after second dose
Israel has been remarkably more efficient than other countries having already vaccinated over 30% of its population. READ: Speedy rollout of vaccine puts Israel ahead of the rest
In New York, as a comparison, Democrat Gov. Andrew Cuomo’s vaccine rollout has been so botched, they are being forced to throw out expiring doses. READ: Cuomo’s rigid COVID-19 vaccine rollout in New York results in 66% unused and expired doses thrown out